ANROVSSTDN• 12 Months (Normalized)
ANRO vs STDN (Alto Neuroscience Inc. vs Standard Nuclear Inc.)
Showing Closing Date Range from Oct 7, 2025 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $23.52
+295.96%
Alto Neuroscience Inc.
Normalized Baseline0.00%
STDN Performance $14.21
+15.53%
Standard Nuclear Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANRO LEADS
+280.43 pts
ANRO outperforming by 280.43 percentage points
ANROSTDN
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO STDN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | ANRO Price | ANRO Gain (%) | STDN Price | STDN Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $23.52 | +295.96% | $14.21 | +15.53% | +280.43% |
| Oct 06, 2026 | $23.69 | +298.82% | $15.19 | +23.50% | +275.32% |
| Oct 05, 2026 | $24.01 | +304.21% | $13.01 | +5.77% | +298.44% |
| Oct 02, 2026 | $24.80 | +317.51% | $12.52 | +1.79% | +315.72% |
| Sep 30, 2026 | $25.88 | +335.69% | $12.03 | -2.17% | +337.86% |
| Sep 29, 2026 | $26.58 | +347.47% | $12.02 | -2.28% | +349.75% |
| Sep 28, 2026 | $26.66 | +348.82% | $11.53 | -6.26% | +355.08% |
| Sep 25, 2026 | $26.49 | +345.96% | $12.34 | +0.33% | +345.63% |
| Sep 24, 2026 | $27.18 | +357.58% | $12.25 | -0.41% | +357.99% |
| Sep 23, 2026 | $27.50 | +362.96% | $12.85 | +4.47% | +358.49% |
| Sep 22, 2026 | $30.78 | +418.18% | $13.02 | +5.85% | +412.33% |
| Sep 21, 2026 | $30.63 | +415.66% | $13.50 | +9.76% | +405.90% |
| Sep 18, 2026 | $30.27 | +409.60% | $12.84 | +4.39% | +405.21% |
| Sep 17, 2026 | $30.98 | +421.55% | $12.49 | +1.54% | +420.01% |
| Sep 16, 2026 | $30.00 | +405.05% | $11.91 | -3.17% | +408.22% |
Page 1 of 17